Filing Flows › Comparisons › TGTX vs TVTX
TG Therapeutics vs Travere Therapeutics: TGTX and TVTX compared
TG Therapeutics is the larger company: $240M of revenue in its latest quarter (Q2 2026) against $225M for Travere Therapeutics (Q3 2026). TG Therapeutics is growing faster (+70% against +36% a year earlier). TG Therapeutics is more profitable, with an operating margin of 9.0% against -30.3%.
Where the money goes: TGTX and TVTX
TG Therapeutics (TGTX) · Q2 2026
TG Therapeutics, Q2 2026: revenue $240M (+70% year over year), operating margin 9.0%, net earnings $7.8M, operating cash flow $39.3M. The chart follows the revenue to costs, profit and cash.
Travere Therapeutics (TVTX) · Q3 2026
Travere Therapeutics, Q3 2026: revenue $225M (+36% year over year), operating margin -30.3%, net loss $52.3M, operating cash flow $98.2M. The chart follows the revenue to costs, profit and cash.
| TG Therapeutics (TGTX) | Travere Therapeutics (TVTX) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 2026 |
| Revenue | $240M | $225M |
| Revenue growth, Y/Y | +70% | +36% |
| Operating margin | 9.0% | -30.3% |
| Net earnings | $7.8M | −$52.3M |
| Net margin | 3.2% | -23.3% |
| Operating cash flow | $39.3M | $98.2M |
| Free cash flow | $39.0M | — |
| Market value | $8.7B | — |
| P/E | 19.7× | — |
| Analysts’ mean target | $69.71 | — |
Where the revenue comes from
TG Therapeutics
- Product: $236M (98%)
- License: $4.5M (2%)
Travere Therapeutics
- Total net product sales: $220M (98%)
- License and collaboration revenue: $4.4M (2%)
Questions
Which is bigger, TG Therapeutics or Travere Therapeutics?
TG Therapeutics is the larger company: $240M of revenue in its latest quarter (Q2 2026) against $225M for Travere Therapeutics (Q3 2026).
Is TG Therapeutics or Travere Therapeutics growing faster?
TG Therapeutics is growing faster (+70% against +36% a year earlier).
Which is more profitable, TG Therapeutics or Travere Therapeutics?
TG Therapeutics is more profitable, with an operating margin of 9.0% against -30.3%.
More: TG Therapeutics earnings · how TG Therapeutics makes money · Travere Therapeutics earnings · how Travere Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 5, 2026; 10-Q filed Nov 2, 2026). Fiscal quarters can end on different dates. Not investment advice.